Filter
1590
Text search:
efficacy
of
medicines
Featured
Recommendations
200
New Publications
430
Language
Document type
No document type
768
Guidelines
326
Studies & Reports
247
Manuals
100
Strategic & Response Plan
68
Fact sheets
33
Training Material
22
Situation Updates
10
Infographics
6
Resource Platforms
5
Brochures
3
Online Courses
1
Videos
1
Countries / Regions
Global
83
India
61
South Africa
50
Kenya
42
Uganda
40
Ethiopia
36
Zambia
31
Nigeria
29
Tanzania
28
Africa
28
Ghana
27
Sierra Leone
24
Western and Central Europe
23
Bangladesh
22
Rwanda
21
Liberia
20
Latin America and the Carribbean
20
Nepal
19
Namibia
18
Malawi
17
Zimbabwe
13
South–East Asia Region
12
Eastern Europe
12
Philippines
11
Ukraine
11
Myanmar / Burma
11
Congo, Democratic Republic of
10
Indonesia
10
Cambodia
9
Eswatini/ Swaziland
9
Lesotho
9
East and Southern Africa
9
Russia
8
Senegal
7
Pakistan
7
Mozambique
7
Botswana
7
West and Central Africa
7
Asia
7
Laos
7
Brazil
6
Guinea
5
Cameroon
5
Middle East and North Africa
5
Vietnam
5
Burkina Faso
4
Afghanistan
4
Thailand
4
Western Pacific Region
4
North America
4
Haiti
3
Lebanon
3
China
3
Sudan
3
Sri Lanka
3
Bhutan
3
United Kingdom
3
Morocco
2
Somalia
2
South Sudan
2
Jordan
2
Syria
2
Chad
2
Benin
2
Argentina
2
Angola
2
Eastern Europe and Central Asia
2
Paraguay
2
Venezuela
2
Albania
2
Iran
2
Gabon
2
Tunisia
2
Mali
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Niger
1
Iraq
1
Germany
1
Turkey
1
Dominican Republic
1
Peru
1
North Macedonia
1
Honduras
1
Ecuador
1
El Salvador
1
Greece
1
Libya
1
Guatemala
1
Madagascar
1
Nicaragua
1
Yemen
1
Fiji
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Australia
1
Georgia
1
Denmark
1
Mauritius
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
592
Clinical Guidelines
203
Public Health
106
Women & Child Health
64
Key Resources
33
Capacity Building
28
Pharmacy & Technologies
23
Toolboxes
HIV
139
AMR
131
COVID-19
115
Pharmacy
113
TB
109
Mental Health
89
Malaria
64
NTDs
63
NCDs
49
Ebola & Marburg
26
Planetary Health
20
Rapid Response
19
Caregiver
19
Disability
16
Refugee
15
Health Financing Toolbox
10
Global Health Education
8
Conflict
6
2.0 Rapid Response
6
Natural Hazards
5
Zika
5
Polio
4
Cholera
2
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social
...
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease
...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, b
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because
...
A review of prospects for existing antibiotics ad new therapeutics
Stories of putting people at the centre
Accessed: 20.11.2019
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of univers
...
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduce
...
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income)
...
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty
...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-neg
...
Integrated Management of pregnancy and childbirth
One of the main aims of the WHO Global Initiative for Childhood Cancer and the CureAll Americas framework is to strengthen centers of excellence an
...
Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors
...
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk
...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Th
...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria tren
...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-
...
